VANCOUVER, March 6, 2018 /CNW/ – InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (CSE: IN; OTCQB: IMLFF), a biopharmaceutical company specializing in the research and development of novel, cannabinoid -based drug therapies, announced today the publication of a peer-reviewed article … Read More
The post InMed Announces Peer-Reviewed Publication in Drug Delivery and Translational Research appeared first on Dagga Magazine.